PHYTOCHEM REMEDIES IPO
Key IPO Details at a Glance
| IPO Period | 18th – 22nd Dec 2025 |
|---|---|
| Listing on | 26 Dec 2025 |
| Price Band | ₹98 per equity share |
| Lot Size & Minimum Investment | 1200 shares amounting to ₹117,600 |
| Total Issue Size | ₹38.22 Crores |
Important Dates for Investors
- Opening Date: 18 Dec 2025
- Closing Date: 22 Dec 2025
- UPI Payment Deadline: 22 Dec 2025 (5 PM)
- Allotment Announcement: 23 Dec 2025
- Refund Processing: 24 Dec 2025
- Demat Credit: 24 Dec 2025
- Stock Market Listing: 26 Dec 2025
- Mandate Validity End: 07 Jan 2026
- Anchor Investor Lock-in Release (50%): 22 Jan 2026
- Anchor Investor Lock-in Release (Remaining): 22 Mar 2026
*Dates may be revised as per official updates.
Exploring Phytochem Remedies: A Business Overview
Incorporated in 2002, Phytochem Remedies (India) Limited (“PRIL”) stands as a key player in the manufacturing of high-quality corrugated packaging products. The company commenced its manufacturing operations in 2014 and has since grown to manage two operational units strategically located in Bari Brahmana, Jammu. This prime location offers significant logistical advantages, enabling efficient distribution and providing substantial capacity for future expansion.
Phytochem Remedies is guided by the vision of its promoters, Niranjan Surana, Shilpa Surana, Aditi Bohra, and Bohra Agrifilms Private Limited. Their leadership has been instrumental in steering the company’s consistent growth and modernisation efforts. The company specialises in crafting a diverse range of corrugated products, including boxes, rolls, sheets, and pads, all meticulously designed to cater to specific sector requirements. Its robust client base spans various vital industries such as pharmaceuticals, agriculture, pesticides, automotive, and fast-moving consumer goods (FMCG), highlighting its broad market penetration.
The manufacturing prowess of Phytochem Remedies is underpinned by its advanced production capabilities. These include a semi-automatic production line complemented by a modern, fully automatic corrugated board plant, which was successfully commissioned in 2022. Operating on a manufacturing-to-order model, the company excels in delivering customised, durable, and cost-effective packaging solutions, thereby generating revenue by meeting bespoke client needs. With an increasing demand for sophisticated packaging across numerous sectors, Phytochem Remedies is well-positioned to leverage its robust operational capabilities and expansion-ready facilities to drive future growth.
Understanding the IPO’s Financial Structure
| Total Funds Raised | ₹38.22 Crores |
|---|---|
| Fresh Issue Component | ₹38.22 Crores |
| Offer for Sale Component | ₹0 Crores |
The IPO of Phytochem Remedies (India) Limited is entirely a fresh issue, aiming to raise a total of ₹38.22 Crores. This means that all proceeds from the offering will directly go to the company, providing capital to fuel its growth initiatives and strengthen its financial standing. There is no Offer for Sale component, indicating that existing shareholders are not selling their shares through this IPO.
Deployment of Fresh Capital: Strategic Utilization
The capital generated through this initial public offering is earmarked for several strategic purposes designed to enhance Phytochem Remedies’ operational capabilities, strengthen its balance sheet, and support its ambitious growth trajectory. The planned utilization of the funds is detailed as follows:
| Objective | Amount (INR Crores) | Allocation % |
|---|---|---|
| Capital expenditure for equipment and machinery | 13.60 | 35.60% |
| Funding capital expenditure towards civil construction | 5.88 | 15.40% |
| Repayment / pre-payment of certain borrowings | 9.37 | 24.50% |
| Issue-related expenses | 3.73 | 9.80% |
| General corporate purposes | 5.64 | 14.80% |
A significant portion, 35.60%, is allocated for capital expenditure on new equipment and machinery, which will enable the company to upgrade its production lines, improve efficiency, and expand its manufacturing capacity. An additional 15.40% is dedicated to civil construction, supporting infrastructure development necessary for planned expansion. Furthermore, 24.50% of the proceeds will be used for the repayment or pre-payment of existing borrowings, which will help reduce the company’s debt burden and improve its financial health. The remaining funds are allocated to cover issue-related expenses and for general corporate purposes, providing flexibility for strategic initiatives and day-to-day operations.
Distinct Advantages and Market Position
Phytochem Remedies possesses several inherent strengths that bolster its competitive standing and potential for sustained growth in the packaging industry:
- Strategic Manufacturing Presence and Expansion Potential: The company benefits from a strategically located manufacturing presence in Jammu, equipped with ample unutilised land. This provides a significant advantage for future expansion, allowing Phytochem Remedies to scale operations without immediate land acquisition challenges.
- Diverse and Customised Product Portfolio: Phytochem Remedies offers a wide array of customised corrugated packaging solutions, catering to a diverse set of industries. This ability to tailor products to specific client needs enhances customer loyalty and market adaptability across various sectors.
- Modern Production Infrastructure: The commissioning of a modern, fully automatic corrugated board plant in 2022 underscores the company’s commitment to technological advancement and efficiency. This state-of-the-art setup ensures high-quality production and improved operational throughput.
- Strong Regional Customer Relationships: With a robust regional customer base and established long-term relationships, Phytochem Remedies enjoys a stable demand for its products. These enduring partnerships are a testament to the company’s consistent quality and reliable service.
- Experienced Promoter-Led Management: The company is led by its promoters, who bring extensive sector experience and a proven track record of consistent operational growth. This experienced leadership provides strategic direction and fosters a culture of innovation and efficiency.
Considering the Investment Risks
While Phytochem Remedies presents several compelling strengths, potential investors should also be aware of certain risk factors that could impact the company’s performance:
- High Customer Concentration: A significant portion of the company’s revenue is derived from a limited number of top clients. This high customer concentration poses a risk, as the loss of any major client could substantially impact its financial performance.
- Dependence on Raw Material Suppliers: Phytochem Remedies heavily relies on its suppliers for raw materials, many of whom do not have long-term agreements. This dependence could expose the company to supply chain disruptions, price volatility, or quality issues.
- Geographic Concentration of Facilities: All manufacturing facilities are concentrated in Jammu. This geographic concentration exposes operations to region-specific risks such as natural disasters, political instability, or changes in regional regulations, potentially affecting production and delivery.
- Outstanding Trade Receivables: The company faces significant outstanding trade receivables, coupled with the inherent risk of delayed customer payments. This could impact cash flow and liquidity management if not effectively controlled.
- Historical Negative Cash Flows: In past periods, the company has reported negative cash flows from operating, investing, and financing activities. While not uncommon for growing businesses, sustained negative cash flows could indicate potential liquidity challenges or a heavy reliance on external funding.
Real-time Investor Interest: Subscription Status
The subscription statistics for the Phytochem Remedies IPO provide an indication of investor interest in the offering. As of 05:00 PM on December 19, 2025, the figures are as follows:
| Investor Category | Shares Reserved (Lakhs) | Shares Applied (Lakhs) | Subscription (Times) |
|---|---|---|---|
| Non-Institutional Investors (NII) | 18.51 | 3.68 | 0.20x |
| Retail Individual Investors (RII) | 18.51 | 5.01 | 0.27x |
| Total | 37.03 | 8.70 | 0.23x |
*Subscription data reflects investor interest as of the specified date and time. It is crucial to monitor updated figures for a complete picture as the IPO progresses.
Participating in the IPO
Investors keen on participating in the Phytochem Remedies IPO can submit their applications through the official Dhan Kirti IPO platform. Ensure your application is submitted well before the subscription window closes on December 22, 2025.
